MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1053/j.gastro.2024.07.038

Медицинская библиотека · Gastroenterology · 2024

Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response.

Cheng Xiangdong, Dai Enyu, Wu Jibo, Flores Natasha M, Chu Yanshuo, Wang Ruiping, Dang Minghao, Xu Zhiyuan, Han Guangchun, Liu Yunhe, Chatterjee Deyali, Hu Can, Ying Jieer, Du Yian, Yang Litao, Guan Xiaoqing, Mo Shaowei, Cao Xuanye, Pei Guangsheng, Jiang Jiahui, Lu Xiaoyin, Benitez Ana Morales, Waters Rebecca E, Pizzi Melissa Pool, Shanbhag Namita, Fan Yibo, Peng Fuduan, Hanash Samir M, Calin George, Futreal Andrew, Song Shumei, Yee Cassian, Mazur Pawel K, Qin Jiang-Jiang, Ajani Jaffer A, Wang Linghua

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND & AIMS: Metastases from gastric adenocarcinoma (GAC) lead to high morbidity and mortality. Developing innovative and effective therapies requires a comprehensive understanding of the tumor and immune biology of advanced GAC. Yet, collecting matched specimens from advanced, treatment-naïve patients with GAC poses a significant challenge, limiting the scope of current research, which has focused predominantly on localized tumors. This gap hinders deeper insight into the metastatic dynamics of GAC.

METHODS

We performed in-depth single-cell transcriptome and immune profiling on 68 paired, treatment-naïve, primary metastatic tumors to delineate alterations in cancer cells and their tumor microenvironment during metastatic progression. To validate our observations, we conducted comprehensive functional studies both in vitro and in vivo, using cell lines and multiple patient-derived xenograft and novel mouse models of GAC.

RESULTS

Liver and peritoneal metastases exhibited distinct properties in cancer cells and dynamics of tumor microenvironment phenotypes, supporting the notion that cancer cells and their local tumor microenvironments co-evolve at metastatic sites. Our study also revealed differential activation of cancer meta-programs across metastases. We observed evasion of cancer cell ferroptosis via GPX4 up-regulation during GAC progression. Conditional depletion of Gpx4 or pharmacologic inhibition of ferroptosis resistance significantly attenuated tumor growth and metastatic progression. In addition, ferroptosis-resensitizing treatments augmented the efficacy of chimeric antigen receptor T-cell therapy.

CONCLUSIONS

This study represents the largest single-cell dataset of metastatic GACs to date. High-resolution mapping of the molecular and cellular dynamics of GAC metastasis has revealed a rationale for targeting ferroptosis defense in combination with chimeric antigen receptor T-cell therapy as a novel therapeutic strategy with potential immense clinical implications.

Для цитирования: Cheng Xiangdong, Dai Enyu, Wu Jibo, Flores Natasha M, Chu Yanshuo, Wang Ruiping, Dang Minghao, Xu Zhiyuan, Han Guangchun, Liu Yunhe, Chatterjee Deyali, Hu Can, Ying Jieer, Du Yian, Yang Litao, Guan Xiaoqing, Mo Shaowei, Cao Xuanye, Pei Guangsheng, Jiang Jiahui, Lu Xiaoyin, Benitez Ana Morales, Waters Rebecca E, Pizzi Melissa Pool, Shanbhag Namita, Fan Yibo, Peng Fuduan, Hanash Samir M, Calin George, Futreal Andrew, Song Shumei, Yee Cassian, Mazur Pawel K, Qin Jiang-Jiang, Ajani Jaffer A, Wang Linghua. Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response.. Gastroenterology. 2024. DOI: 10.1053/j.gastro.2024.07.038.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.